The Clinical Usefulness of Focally Enhanced Gastritis in Korean Patients with Crohn's Disease.
- Author:
Cheul Ho HONG
1
;
Dong Il PARK
;
Woo Hyuk CHOI
;
Jung Ho PARK
;
Hong Joo KIM
;
Yong Kyun CHO
;
Chong Il SOHN
;
Woo Kyu JEON
;
Byung Ik KIM
;
Dong Hoon KIM
;
Min Kyung KIM
;
Seung Wan CHAE
;
Kyoung Bun LEE
;
Jin Hee SOHN
;
Suk Joong OH
Author Information
1. Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. diksmc.park@samsung.com
- Publication Type:Original Article ; Comparative Study ; English Abstract
- Keywords:
Crohn's disease;
Ulcerative colitis;
Focally enhanced gastritis;
Inflammatory bowel disease
- MeSH:
Adult;
Colitis, Ulcerative/*diagnosis/etiology/pathology;
Crohn Disease/*diagnosis/etiology/pathology;
Female;
Gastritis/epidemiology/*pathology;
Gastroscopy;
Humans;
Korea/epidemiology;
Male;
Middle Aged;
Upper Gastrointestinal Tract/pathology
- From:The Korean Journal of Gastroenterology
2009;53(1):23-28
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Focally enhanced gastritis (FEG) has been suggested as a specific diagnostic marker for patients with Crohn's disease (CD). However, the usefulness of FEG for distinguishing CD from ulcerative colitis (UC) is uncertain and the incidence or prevalence of FEG for inflammatory bowel disease (IBD) patients in Korea has not been defined yet. In this study, we investigated the frequency of FEG and other gastric histological abnormalities in Korean patients with CD and UC. METHODS: We evaluated 37 patients with known CD, 43 patients with UC and 41 non-IBD control group; all underwent upper gastrointestinal endoscopy followed by biopsy from the antrum and the body. The pathology of the gastric biopsy specimens and the presence of Helicobacter pylori (H. pylori) were evaluated. FEG was characterized by a focal perifoveolar or periglandular inflammatory cell infiltrates. RESULTS: H. pylori positive gastritis was found in 10 of 37 (27.0%) of CD patients, in 16 of 43 (37.2%) of UC patients, and in 22 of 41 (53.7%) of non-IBD control group (p=0.054). In H. pylori-negative patients, FEG was found in 8 of 27 patients (29.6%) of CD patients, 6 of 27 (22.2%) patients with UC, and 2 of 9 (10.5%) of non-IBD control group (p=0.324). CONCLUSIONS: In H. pylori-negative patients, there was no statistically significant difference in the occurrence of FEG among CD, UC and control groups in Korea.
